Anti-COVID-19 2-DG drug developed by DRDO was first studied by Patanjali, claims Acharya Balkrishna
New Delhi: 2-deoxy-D-glucose (2-DG), the anti-COVID-19 drug that has been developed by Defence Research and Development Organisation (DRDO) and been given an emergency use nod by Drugs […]